US OptionsDetailed Quotes
LNTH250117P145000
- 31.90
- 0.000.00%
15min DelayClose Jan 7 16:00 ET
0.00High0.00Low
31.90Open31.90Pre Close0 Volume0 Open Interest145.00Strike Price0.00Turnover111.22%IV-16.69%PremiumJan 17, 2025Expiry Date48.08Intrinsic Value100Multiplier10DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type-0.9896Delta0.0030Gamma2.01Leverage Ratio-0.0147Theta-0.0101Rho-1.99Eff Leverage0.0041Vega
Lantheus Stock Discussion
$XPeng (XPEV.US)$ stock rose 15.56%. Shares of Chinese stocks gained following an increase in China's June exports.
$QuantumScape (QS.US)$ stock jumped 64.34% after the company announced it entered into an agreement with Volkswagen $VOLKSWAGEN A G (VWAGY.US)$ 's battery company PowerC...
$Lantheus (LNTH.US)$ : “I think it’s great..Lantheus is terrific.”
$BeiGene (BGNE.US)$ : Approved 3/8 🎉
⇒ BRUKINSA + obinutuzumab
⇒ Follicular Lymphoma
⇒ sNDA
⇒ PDUFA date: Mar 2024
$Bristol-Myers Squibb (BMY.US)$ : Approved 3/8 🎉
⇒ Opdivo ® + Cisplatin & Gemcitabine
⇒ Urothelial carcinoma
⇒ sBLA
⇒ PDUFA: 04/05/24
$Vanda Pharmaceuticals (VNDA.US)$ : CRL 3/4 🙁
⇒ HETLIOZ®
⇒ insomnia
⇒ sNDA
⇒ PDUFA: 03/04/24
$Eyenovia (EYEN.US)$ : Approved 3/4 🎉
⇒ Clobetasol propionate ophthalmic susp. 0.05% (APP13007)
⇒ postop eye pa...
No comment yet